Trident Texofab standalone net profit declines 60.00% in the September 2019 quarter
Sales rise 26.66% to Rs 22.38 crore
Net profit of Trident Texofab declined 60.00% to Rs 0.14 crore in the quarter ended September 2019 as against Rs 0.35 crore during the previous quarter ended September 2018. Sales rose 26.66% to Rs 22.38 crore in the quarter ended September 2019 as against Rs 17.67 crore during the previous quarter ended September 2018. ParticularsQuarter EndedSep. 2019Sep. 2018% Var.Sales22.3817.67 27 OPM %5.324.64 -PBDT0.460.57 -19 PBT0.250.55 -55 NP0.140.35 -60Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content